Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Amino acids content in the blood serum of patients with multiple sclerosis.]
Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients.
The New Era of Multiple Sclerosis Therapeutics.
Aurintricarboxylic Acid Ameliorates Experimental Autoimmune Encephalomyelitis by Blocking Chemokine-Mediated Pathogenic Cell Migration and Infiltration.
Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease.
New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds.
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
Prolactin Is Not Required for the Development of Severe Chronic Experimental Autoimmune Encephalomyelitis.
Neuroinflammation: The role and consequences.
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
Deep-brain stimulation for Parkinson's disease.
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Cognitive reserve in multiple sclerosis: Protective effects of education.
Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study.
ISENTRESS® prescribing information
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Pages